Main > ONCOLOGY (**) > Liver Cancer *** > Treatment. > DE. B. HCC>TREAT.>Regorafenib>*

---

DE. B. HCC>TREAT.>Regorafenib>*'s subsections
(*) USA Approval Date: 2017. 04.28
>Previously Treated with Sorafenib>
Company
Oral Multi KInase Inhibition
Patent>Assignee; Claims; No.; Etc.
Patent>Total USA No.: 4
Patent>UpDate: 2017. 04.25
TradeMark
TradeMark Web-Site
UpDate: 2017. 04.29

DE. B. HCC>TREAT.>Regorafenib>*'s products
This section has no products